Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status

• Status: Unknown status
• Trial end date: 2014-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

GLP-1 receptor agonists promote fat redistribution in obese women with type 2 diabetes, reduce liver fat content, improve the inflammation state

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shanghai 10th People's Hospital
• Treatments: Exenatide

Criteria

Inclusion Criteria:

• Clinical diagnosis of overweight and type 2 diabetes mellitus

Exclusion Criteria:

• Poor body condition (severe liver and kidney dysfunction)

• Unknown causes of pancreatitis, chronic pancreatitis, pancreatic resection, stomach operation, malignant tumor, previous use of systemic corticosteroids (local or inhalation of exceptions) heart function or niacin, incomplete

• serious endocrine disease

• genetic disease